Application of hepatic cytochrome b/P450 reductase null (HBRN) mice to study the role of cytochrome b in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
about
Application of hepatic cytochrome b/P450 reductase null (HBRN) mice to study the role of cytochrome b in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
description
im März 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 25 January 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2019
@uk
name
Application of hepatic cytochr ...... he anticancer drug ellipticine
@en
Application of hepatic cytochrome b/P450 reductase null
@nl
type
label
Application of hepatic cytochr ...... he anticancer drug ellipticine
@en
Application of hepatic cytochrome b/P450 reductase null
@nl
prefLabel
Application of hepatic cytochr ...... he anticancer drug ellipticine
@en
Application of hepatic cytochrome b/P450 reductase null
@nl
P2093
P1476
Application of hepatic cytochr ...... he anticancer drug ellipticine
@en
P2093
C Roland Wolf
Colin J Henderson
David H Phillips
Heinz H Schmeiser
Iveta Mrizova
Lindsay Reed
Marie Stiborova
Michaela Moserova
P356
10.1016/J.TAAP.2019.01.020
P407
P577
2019-01-25T00:00:00Z